Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carol Addy

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
American Journal of Health Promotion : AJHP|May 25, 2017
Association of Wage With Employee Participation in Health Assessments and Biometric ScreeningBruce W Sherman, Carol Addy
The American Journal of Managed Care|July 19, 2018
Value-based health insurance design: how much does socioeconomic status matter?Bruce W Sherman, Carol Addy
Health Affairs (Project Hope)|February 8, 2017
Health Care Use And Spending Patterns Vary By Wage Level In Employer-Sponsored PlansBruce W Sherman, Teresa B Gibson, Wendy D Lynch, et al.
Plos One|April 19, 2018
High intensity lifestyle intervention and long-term impact on weight and clinical outcomesLinda Gotthelf, Ya-Ting Chen, Srinivasan Rajagopalan, et al.
The Journal of Clinical Endocrinology and Metabolism|December 23, 2004
Recombinant methionyl human leptin administration to achieve high physiologic or pharmacologic leptin levels does not alter circulating inflammatory marker levels in humans with leptin sufficiency or excessJean L Chan, John Bullen, Violeta Stoyneva, et al.
Journal of Diabetes Investigation|May 17, 2016
Single and multiple dose pharmacokinetics and pharmacodynamics of omarigliptin, a novel, once-weekly dipeptidyl peptidase-4 inhibitor, in healthy Japanese menSaori Tsuchiya, Evan Friedman, Carol Addy, et al.
The Journal of Clinical Endocrinology and Metabolism|March 12, 2003
Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in GreeceEleni Petridou, Christos Mantzoros, Nick Dessypris, et al.
Clinical Pharmacology in Drug Development|September 15, 2016
Effects of Age, Sex, and Obesity on the Single-Dose Pharmacokinetics of Omarigliptin in Healthy SubjectsCarol Addy, Daniel A Tatosian, Xiaoli S Glasgow, et al.
The AAPS Journal|June 29, 2010
Development of a population pharmacokinetic model for taranabant, a cannibinoid-1 receptor inverse agonistXiujiang Susie Li, Jace Nielsen, Brenda Cirincione, et al.
Journal of Clinical Pharmacology|September 29, 2009
Pharmacokinetics, safety, and tolerability of phentermine in healthy participants receiving taranabant, a novel cannabinoid-1 receptor (CB1R) inverse agonistCarol Addy, Patricia Jumes, Kimberly Rosko, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
American Journal of Health Promotion : AJHP|May 25, 2017
Association of Wage With Employee Participation in Health Assessments and Biometric ScreeningBruce W Sherman, Carol Addy
The American Journal of Managed Care|July 19, 2018
Value-based health insurance design: how much does socioeconomic status matter?Bruce W Sherman, Carol Addy
Health Affairs (Project Hope)|February 8, 2017
Health Care Use And Spending Patterns Vary By Wage Level In Employer-Sponsored PlansBruce W Sherman, Teresa B Gibson, Wendy D Lynch, et al.
Plos One|April 19, 2018
High intensity lifestyle intervention and long-term impact on weight and clinical outcomesLinda Gotthelf, Ya-Ting Chen, Srinivasan Rajagopalan, et al.
The Journal of Clinical Endocrinology and Metabolism|December 23, 2004
Recombinant methionyl human leptin administration to achieve high physiologic or pharmacologic leptin levels does not alter circulating inflammatory marker levels in humans with leptin sufficiency or excessJean L Chan, John Bullen, Violeta Stoyneva, et al.
Journal of Diabetes Investigation|May 17, 2016
Single and multiple dose pharmacokinetics and pharmacodynamics of omarigliptin, a novel, once-weekly dipeptidyl peptidase-4 inhibitor, in healthy Japanese menSaori Tsuchiya, Evan Friedman, Carol Addy, et al.
The Journal of Clinical Endocrinology and Metabolism|March 12, 2003
Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in GreeceEleni Petridou, Christos Mantzoros, Nick Dessypris, et al.
Clinical Pharmacology in Drug Development|September 15, 2016
Effects of Age, Sex, and Obesity on the Single-Dose Pharmacokinetics of Omarigliptin in Healthy SubjectsCarol Addy, Daniel A Tatosian, Xiaoli S Glasgow, et al.
The AAPS Journal|June 29, 2010
Development of a population pharmacokinetic model for taranabant, a cannibinoid-1 receptor inverse agonistXiujiang Susie Li, Jace Nielsen, Brenda Cirincione, et al.
Journal of Clinical Pharmacology|September 29, 2009
Pharmacokinetics, safety, and tolerability of phentermine in healthy participants receiving taranabant, a novel cannabinoid-1 receptor (CB1R) inverse agonistCarol Addy, Patricia Jumes, Kimberly Rosko, et al.
Pageof 3